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In addition to their established role in repairing post-
replicative DNA errors, DNA mismatch repair proteins
contribute to cell cycle arrest and apoptosis in response
to a wide range of exogenous DNA damage (e.g., alky-
lation-induced lesions). The role of DNA mismatch
repair in response to ultraviolet-induced DNA damage
has been historically controversial. Recent data, however,
suggest that DNA mismatch repair proteins probably
do not contribute to the removal of ultraviolet-induced
DNA damage, but may be important in suppressing
mutagenesis, e¡ecting apoptosis, and suppressing tu-
morigenesis following exposure to ultraviolet radiation.
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T
he highly conserved DNA mismatch repair (MMR)
proteins contribute to DNA replication ¢delity by
removing insertion/deletion loops that result from
template primer slippage at repetitive DNA se-
quences and correcting single base mismatches that
escape polymerase proofreading. If left unrepaired, such errors
will give rise to permanent mutations in the genome of the af-
fected cell. Hereditary nonpolyposis colon cancer is associated
with the loss of function of one or more of the MMR proteins
and underlines the importance of MMR to the maintenance of
genomic stability and the prevention of cancer.
The process of MMR is best characterized in Escherichia coli
and is thought to occur in ¢ve steps (recently reviewed by Marti
et al, 2002): (1) recognition of the DNA lesion by the MutS
homodimer; (2) interaction of the mismatch-bound MutS homo-
dimer with both ATP and the MutL homodimer, resulting in ac-
tivation of the MutS-MutL complex; (3) identi¢cation of the
nascent DNA by MutH endonuclease through the recognition
of hemimethylation at GATC sequences; (4) removal of up to
1000 bases in the nascent DNA surrounding the lesion by pro-
cesses involving MutH endonuclease, MutU (also known as
UvrD and DNA helicase II), and exonucleases speci¢c for single
strand DNA; and (5) resynthesis of DNA by the replicative PolIII
holo-enzyme. In eukaryotes, MutS and MutL are represented by
multiple orthologs (Table I). The MutS homodimer is repre-
sented in eukaryotes by Muta and MutSb heterodimers. MutSa,
comprising Msh2 and Msh6, primarily recognizes single base
mismatches and short insertion-deletion loops in the DNA (typi-
cally one to two nucleotides). MutSb, comprising Msh2 and
Msh3, recognizes larger loops (42 nucleotides). In the absence
of Msh3, the MutSa heterodimer can partially compensate for
the lack of MutSb. However, MutSb can only minimally com-
pensate for the lack of MutSa, when Msh6 is absent (reviewed
by Aquilina and Bignami, 2001; Marti et al, 2002). MutL also is
represented in the eukaryotes by several heterodimers. Eukaryotic
Mlh1 and Pms2 bind to form a MutL heterodimer (or MutLa)
and, more recently, orthologs Mlh3 and Pms1 also have been
identi¢ed and shown to dimerize with Mlh1 (reviewed by Marti
et al, 2002). Compared to Mlh1 and Pms2, little is known about
the role of Pms1 and Mlh3 in response to postreplicative or exo-
genous DNA damage. Unlike MutS and MutL, eukaryotic
orthologs for MutH and MutU have not been identi¢ed and the
processes of strand recognition in eukaryotes have not been resol-
ved. However, MMR proteins, bind to, or are associated with,
proteins that are required for excision of lesions and resynthesis of
the DNA strand (e.g., ExoI and proliferating cell nuclear antigen).
In addition to a critical role in correcting base mismatches,
there is evidence to suggest that MMR is involved in the cellular
response to DNA lesions formed by some exogenous or endo-
genous substances. For example, MMR is thought to contribute
to recognition of some oxidation-induced lesions in a replication
context and levels of mutations caused by oxidized bases are in-
creased in MMR-defective cells (Earley and Crouse, 1998; Jackson
et al, 1998; Ni et al, 1999; Mazurek et al, 2002). MMR-de¢cient
cells are also resistant to the cytotoxic e¡ects of oxidizing agents
(Hardman et al, 2001). Additionally, MMR proteins bind
O6-meG DNA adducts formed by some alkylating agents, speci-
¢cally SN1 methylating agents (e.g., N-methyl-N0-nitro-N-ni-
trosoguanidine, MNNG), and loss of MMR confers strong
resistance to these agents (deWind et al, 1995; Duckett et al, 1996;
Hickman and Samson, 1999; Karran, 2001). Similarly, loss of
MMRconfers partial resistance to cisplatin (cis diamminedichloro-
platinum),
and MMR proteins bind to DNA containing cisplatin adducts
(Duckett et al, 1996; Mu et al, 1997; Reitmair et al, 1997; Gong
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et al, 1999). Such partial or complete resistance conferred by
MMR de¢ciency often corresponds with a failure to apoptose in
response to DNA damage (Gong et al, 1999; Hickman and Sam-
son, 1999; Hardman et al, 2001; Meyers et al, 2001). Also, MMR
has been shown to facilitate cell cycle arrest in the G2M transi-
tion in response to DNA damage (Hawn et al, 1995; Davis et al,
1998; Lan et al, 2002). Therefore, depending on the type of DNA
damage, loss of MMRmay result in loss of cell cycle control and/
or resistance to apoptosis, both of which promote neoplastic
transformation. The ability of MMR to contribute to the postre-
plicative repair of single base mismatches and loops, to contribute
to the removal of some endogenous and exogenous DNA lesions,
as well as to in£uence cell cycle arrest and apoptosis in response
to some exogenous DNA damage illustrates the versatility of
MMR for the maintenance of genomic integrity.
Interaction of the MMR systemwith ultraviolet (UV) induced
DNA damage was observed as early as 20 y ago in E. coli, and
since then has been directly investigated in E. coli, Saccharomyces
cerevisiae, and mammals. However, likely due to the diversity of
model organisms, cell lines, and UV dosages employed the role
of MMR in post-UV responses has been controversial. A num-
ber of studies with mammalian cell lines have found no
e¡ect of MMR de¢ciency on UV-induced toxicity or mutagen-
esis. Other studies, however (some unpublished), have revealed a
potentially important role for MMR in response to UV-induced
DNA damage. By integrating this wide body of literature, we in-
tend to provide a more complete picture of the role of MMR in
post-UV response.We will address the ability of MMR proteins
to bind photoproducts, a¡ect the removal of these photoproducts,
contribute to maintenance of post-UVgenetic stability, and e¡ect
UV-induced apoptosis. In addition, we will summarize the
responses of MMR-de¢cient mice to UV radiation and data
pertaining to the MMR status of human skin cancers.
BINDING OF MMR PROTEINS TO PHOTOPRODUCTS
Although UVC radiation (200^290 nm) primarily induces cyclo-
butane pyrimidine dimers (CPDs) and [6^4]photoproducts, UVB
(290^320 nm) and especially UVA (320^400 nm) produce reac-
tive oxygen species in addition to photoproducts. Reactive oxy-
gen species generate a wide variety of oxidized bases in DNA
(e.g., thymine glycols and 8-oxoguanine) and MMR is impor-
tant to the processing of oxidative DNA damage (Leadon and
Avrutskaya, 1998; Hardman et al, 2001; Mazurek et al, 2002). How-
ever, mutation spectra from human skin tumors and the increased
incidence of UVB-induced skin cancers in nucleotide excision
repair (NER) de¢cient patients both indicate, that DNA damage
generated by UVB radiation is more mutagenic than that gener-
ated by reactive oxygen species. Therefore, this review will focus
on the role of MMR in response to UV-induced DNA photo-
products.
The two primary DNA adducts caused by UV radiation
are cissyn CPDs and (6^4) pyrimidine-pyrimidinones (or
[6^4]photoproducts). The adjacent pyrimidines can be either
thymine or cytosine, with some preferences at 50 and 30 positions
(e.g., thymine dimer CPDs (T[CPD]T) is more abundant than
T[6^4]T, but T[6^4]C is more abundant thanT[CPD]C (Ravanat
et al, 2001)). CPDs are considered more mutagenic than
[6^4]photoproducts. However, T[CPD]T, which is the most
abundant CPD, does not give rise to the majority of permanent
UV-induced mutations (Ravanat et al, 2001). UV mutation spec-
tra are dominated by C-T transitions, with CC-TTandT-C
also occurring (Ravanat et al, 2001).
Regardless of whether MMR participates directly in the repair
of photoproducts or acts as a general sensor of DNA damage
modulating post-UV responses, MMR proteins (MutSa and/or
MutSb) would be predicted to interact with UV-induced photo-
products.When studying the relative binding a⁄nities of MutS
orthologs for oligoduplexes representing undamaged, mismat-
ched, and/or photodamaged DNA, there are two relevant situa-
tions for examination: (1) an undamaged oligoduplex compared
to an oligoduplex containing a single photoproduct lesion (sim-
ple lesion) and (2) an oligoduplex containing a photoproduct le-
sion compared to an oligoduplex with an incorrect nucleotide
inserted opposite the photoproduct (compound lesion).
Comparing an undamaged oligoduplex to an oligoduplex
containing either a CPD or a [6^4]photoproduct, the addition of
a photoproduct to an undamaged oligoduplex may decrease
slightly the binding a⁄nity of hMutSa (Mu et al, 1997; Wang
et al, 1999). In the compound lesion case, the insertion of a mis-
match opposite a preexisting photoproduct (e.g.T[CPD]T/AA-
T[CPD]T/AG) is an expected result of error-prone translesion
synthesis across a photoproduct (Wang et al, 1999). Mu et al
(1997) tested the e¡ect of such mismatched nucleotides opposite
the 50 nucleotide of a CPD and found that the addition of a 50
mismatch increased the a⁄nity of hMutSa for these photopro-
ducts.Wang et al (1999) tested the e¡ect of mismatched nucleo-
tides opposite the 30 nucleotide of both [6^4]photoproducts and
CPDs, typically the sites of most UV-induced mutations, and
found that the insertion of a mismatch increased the a⁄nity of
hMutSa for the photoproducts. Relative to matched counter-
parts, a⁄nities of MutSa for photoproduct/base mismatches were
somewhat less than for base/base mismatches, but were within the
a⁄nity range apparently compatible with base/base mismatch
correction (Wang et al, 1999). Moreover, recent unpublished work
(P. Ho¡man and J.B. Hays) demonstrates that the binding of E.
coli MutS to mismatched photoproducts is conserved, but sug-
gests some complexities in recognition of these mismatches that
may be related to the degree of distortion, in£uenced by both the
type of photoproduct and the position of the mismatch.
These data clearly support the concept of the MutS heterodi-
mer binding to UV-induced DNA damage, as has been observed
for other MMR-associated lesions including oxidized and alky-
lated bases (Duckett et al, 1996; Mazurek et al, 2002). In the cases
of CPDs and [6^4]photoproducts formed by UV radiation, and
8-oxoguanine formed by oxidizing agents, MutS heterodimers
show preferences for those lesions containing a mismatched base,
providing an opportunity for MMR to antagonize UV- and re-
active-oxygen-species-induced mutations. Therefore, MMR pro-
teins are perfectly poised to modulate cellular responses to such
DNA damage.
DNA REPAIR
Bulky lesions such as UV-induced photoproducts are removed
from the mammalian genome by NER, and speci¢cally from
template strands of transcribed genes by transcription coupled re-
pair (TCR) (de Gruijl et al, 2001). Although yeast MMR proteins
Table I. Nomenclature of MMR proteins involved in the
repair of postreplicative and exogenous DNA damage
Eukaryote
E. coli S. cerevisiae Mouse Human
MutS Msh2p Msh2 MSH2
Msh3p Msh3 MSH3
Msh6p Msh6 MSH6





MutH ^ ^ ^
MutU/UvrD/EvrE/ecL ^ ^ ^
Proteins involved in recombination are not addressed.
^, no ortholog identi¢ed.
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have been found to physically interact with NER proteins
(Bertrand et al, 1998) and hMutSa to bind to photopro-
ductmismatch compound lesions (Mu et al, 1997; Wang et al,
1999), these interactions do not necessarily indicate a role for
MMR in the process of photoproduct repair. The TCR of CPDs
has been investigated in E. coli, yeast, and mammalian cells with
varied conclusions. In some instances opposing results have been
found using similar experimental approaches.
One common repair assay used to measure repair of CPDs ex-
ploits the ability of T4 endonucleaseV to cleave DNA speci¢cally
at CPD. DNA samples are digested with T4 endonuclease V and
levels of the transcribed strand or the nontranscribed strand of a
speci¢c gene are determined by Southern blot analysis. Reap-
pearance of the transcript is indicative of repair and TCR is char-
acterized by a more rapid repair of the transcribed strand. Using
this assay, two separate research groups have investigated TCR in
MMR-de¢cient E. coli with opposing results; both groups com-
pared MMR-de¢cient strains to wild-type E. coli and E. coli lack-
ing the TCR protein Mfd. The ¢rst group, Mellon and Champe
(1996), found that TCR is lost completely in E. coli strains lacking
MutL and MutS, but not MutH, following UVC exposure.
Moreover, the repair levels in these MMR-de¢cient strains were
similar to those observed for a TCR-defective E. coli strain. The
second research group, Li and Bockrath (1995a), found that in
comparison to wild-type strains UVC-irradiated MMR-de¢cient
E. coli demonstrated no decrease or only a minimal decrease (de-
pending on parental strain) in the repair of the lactose operon,
and that any decrease was never to the same degree as observed
in TCR-defective E. coli. Using a di¡erent repair assay, Selby and
Sancar (1995) observed that cell-free extracts from MutS-de¢cient
E. coli were pro¢cient at TCR of a UVC-irradiated plasmid and
that supplementation with puri¢ed MutS protein did not increase
TCR e¡ectiveness.
In contrast, additional repair assays performed in yeast clearly
support the concept that MMR is not directly involved in the
repair of UV-induced photoproducts. S. cerevisiae strains defective
in Msh2p, Msh3p, Mlh1p, Pms1p, Msh3p/Msh2p, or Mlh1p/
Pms1p do not have alterations in levels of either TCR or global
genomic repair of UVC-induced CPDs, compared to wild-type
controls (Sweder et al, 1996; Leadon and Avrutskaya, 1998).n
Using isogenic transformed mouse embryonic ¢broblasts
(MEFs), immortalized kidney cells, and primary mouse dermal
¢broblasts, it has been demonstrated that there is no reduction
inTCRof CPD inMsh2-null andMlh1-null cells over wild-type
control cells (Sonneveld et al, 2001; Shin et al, 2002). Other data
supporting MMR-independent TCR of CPDs in mammals in-
clude (1) pro¢cient TCR of UVB-induced CPDs in the MSH6-
de¢cient DLD1 adenocarcinoma cell line (Therrien et al, 2001); (2)
unaltered excision rates of mismatchphotoproduct compound
lesions after restoration of MMR protein levels in cell extracts
from the PMS2-de¢cient HEC-1-A and MSH2-de¢cient LoVo
cell lines (Mu et al, 1997); (3) pro¢cient TCR of UVB-
and UVC-induced CPDs in the MLH1-de¢cient HCT-116 colon
cancer cell line (Adimoolam et al, 2001; Rochette et al, 2002); (4)
e¡ective RNA synthesis in the HCT-116 cell line following
either UVB or UVC irradiation (Rochette et al, 2002); and (5)
MMR-independent degradation of RNA polymerase II (McKay
et al, 2001).
Conversely, Mellon et al (1996) demonstrated a decrease in
TCR of UVC-induced CPDs in MMR-de¢cient human cancer
cell lines using the endonuclease-V-based TCR assay. Also using
tumor-derived cell lines, Leadon and Avrutskaya (1997) demon-
strated that MMR-de¢cient cells have reduced levels of rapid
TCR following exposure to ionizing radiation or UVC radia-
tion. In these experiments the cells were labeled with BrdUrd
and FdUrd prior to irradiation in order to separate replicated
and nonreplicated DNA. However, recent research has shown
that MMR in£uences the cellular responses to these compounds
(cytotoxicity, cell cycle arrest, removal of BrdUrd from genome)
and BrdUrd sensitizes MMR-de¢cient cells to ionizing-radiation-
induced cytotoxicity (Berry et al, 1999; 2000; Meyers et al, 2001).
In the light of this more recent knowledge, the data of Lea-
don and Avrutskaya are di⁄cult to interpret.n n
Surveying the data pertaining to the role of MMR in the
TCR of CPDs, it is di⁄cult to make de¢nite conclusions. In E.
coli and mammalian cells there is evidence both for and against
the hypothesis that MMR is involved in the repair of CPDs,
whereas in S. cerevisiae MMR does not appear to be necessary
for the repair of CPDs. The balance of the data for both the yeast
and mammalian cells, however, favors MMR-independent repair
of UV-induced photoproducts.
MUTAGENESIS AND GENOMIC INSTABILITY
MMR still has a potential role in counteracting UV-induced
genomic instability, even if MMR does not participate in the
excision and/or repair of photoproducts. Incorrect bases may be
inserted opposite a photoproduct during error-prone translesion
synthesis, thus creating a compound lesion. This misincorporated
base, as well as the corresponding photoproduct, must be repaired
to avoid generating permanent mutations.
Although initial investigations into the role of MMR in
UV-induced mutagenesis and toxicity began some years prior
(McGraw and Marinus, 1980; Caillet-Fauquet and Maenhaut-
Michel, 1988), it was not until 1991 that Feng, Lee, and Hays (Feng
et al, 1991) were able to demonstrate direct interaction between
MMR and UV-damaged DNA in E. coli. Their data suggest that
UV photoproducts provoke MMR-dependent nicks through
both strands of nonreplicating DNA at unmethylated GATC
sequences, thus producing recombinagenic double-strand breaks;
MMR-de¢cient strains have reduced levels of recombination
(Feng et al, 1991; Feng and Hays, 1995). More recently, MMR-
de¢cient strains of S. cerevisiae and E. coli have been found to
show a higher mutation frequency after UVC irradiation than
wild-type controls (Li and Bockrath, 1995b; Durant et al, 1999;
Liu et al, 2000).
In mammalian cells, the contribution of MMR to the suppres-
sion of UV-induced mutagenesis has been less clearly de¢ned.
Using spontaneously immortalized mouse kidney cells generated
from Mlh1- and Pms2-null mice, Shin et al (2002) did not detect
an MMR-dependent di¡erence in overall UV-induced mutation
rates. However, they did observe, that following UVC irradiation
the MMR-de¢cient cells, compared to wild-type controls, had
increased numbers of UV-signature C-T mutations (primarily
on the nontranscribed strand), increased numbers of mutations
arising from two or three base pair substitutions, and greater loss
of heterozygosity (Shin et al, 2002). Additionally, another study
showed that loss of MMR from NER-de¢cient cells increased
UVC-induced mutations several hundred-fold (Nara et al, 2001),
although a separate study found no increase in levels of sister
chromatid exchange (O’Driscoll et al, 1999). Moreover, observa-
tions that embryonic stem cells from Msh2-null mice are hyper-
mutable following UVC irradiation1 and two di¡erent strains of
Msh2-null mice develop UVB-induced skin tumors earlier
than wild-type control mice2 (Meira et al, 2001; Yoshino et al,
2002) are consistent with the theory that mammalian MMR sup-
presses UV-induced mutagenesis.
Thus, loss of MMR clearly in£uences UV-induced mutagen-
esis and genomic instability in both E. coli and S. cerevisiae. For
mammalian cells there is not yet consensus on the relationship
between loss of MMR and increased mutagenesis post-UV, but
some data strongly suggest that loss of MMR results in increased
UV-induced mutagenicity.
Manuscript retracted, Leadon. SA, DNA Repair 2003.
1V. Borgdor¡ and N. deWind, personal communication, 2002.
2Also L.C. Young et al, unpublished data.
Manuscript retracted, Cancer Research, 2003.
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POST-UV CELLULAR RESPONSES
The observation that MutS orthologs bind to photoproducts,
taken with the proposal that MutS orthologs in£uence UV-
induced mutability without directly removing these adducts,
infers that MMR acts as a sensor or mediator of UV-induced
DNA damage. In addition to its role in error correction, MMR
is required for apoptosis (Gong et al, 1999; Hickman and Samson,
1999; Hardman et al, 2001; Meyers et al, 2001) and G2M cell cycle
arrest (Hawn et al, 1995; Davis et al, 1998; Lan et al, 2002) in
response to some chemical carcinogens. Furthermore, overexpres-
sion of MMR proteins is su⁄cient to induce apoptosis (Zhang
et al, 1999). The association of MMR de¢ciency with increased
UV-induced mutagenesis, but not removal of photoproducts
from DNA, suggests that, independent of the possibility that
MMR removes incorrect nucleotides opposite photoproducts,
MMR may be involved in the elimination of mutated cells by
in£uencing UV-induced apoptosis and cell cycle arrest.
Both E. coli MMR-de¢cient mutants (Caillet-Fauquet et al,
1984; Mellon and Champe, 1996; Qiu et al, 1998) and S. cerevisiae
MMRmutants (Bertrand et al, 1998; Durant et al, 1999) have simi-
lar or increased levels of UVC-induced cell death compared to
wild-type control strains. Neither bacteria nor yeast, however,
are known to actively complete a cell death program to eliminate
overly damaged cells, probably because they are individual
entities and are not programmed to protect a complex multicel-
lular organism.
In mammalian cells, studies of cell survival after UV irradia-
tion are contradictory. Comparing MMR-pro¢cient and
-de¢cient colon cancer cell lines, Mellon et al (1996) demonstrated
that the MMR-de¢cient cells were sensitized to UVC-induced
cell death. Using the same cell lines plus two additional colon
cancer cell lines, Leadon and Avrutskaya (1997) did not observe
an MMR-dependent di¡erence in survival following UVC irra-
diation. Fritzell et al (1997) compared Pms2-null and wild-type
MEFs immortalized with SV40 T antigen and demonstrated that
the MMR-de¢cient cells were marginally more sensitive to
UVC-induced cell death. Also using SV40 transformed cell lines,
O’Driscoll et al (1999) found that ¢broblasts de¢cient in both
NER and MMRdid not have altered UVC sensitivity compared
to a cell ¢broblast line that was NER de¢cient and MMR pro¢-
cient. Similar results were found in NER-de¢cient Chinese ham-
ster ovary cell lines that had lost MMR through selection with
the alkylating agent MNNG (Nara et al, 2001). However, Ichika-
wa et al (2000), found that MMR function was lost in some
UVB-induced skin tumors from xeroderma pigmentoosum group A
(XPA) null mice and that loss of MMR was associated with
decreased UV sensitivity of the XPA-null cells.
These con£icting studies have in common that they were
performed using tumor-derived cell lines or transformed cells,
which may have acquired additional genetic alterations. An inter-
esting study by Reitmair et al (1997) compared Msh2-null and
wild-type MEFs that had been immortalized with E7/Ras with
MEFs that had undergone spontaneous immortalization. In
comparison with the appropriate wild-type control, E7/Ras-
transformed Msh2-null MEFs were more sensitive to UVC,
whereas spontaneously immortalized Msh2-null MEFs were
more resistant to UVC (Reitmair et al, 1997). Moreover, di¡erent
methods of immortalization have been shown to alter UV-in-
duced cytotoxicity and mutagenesis, as well as removal of CPDs
(Parris and Kraemer, 1992; Cleaver et al, 1999; Bowman et al,
2000). These data demonstrate that transformation a¡ects post-
UV survival and complicates the comparison of MMR-pro¢cient
and -de¢cient cells. The same proteins targeted by immortaliza-
tion are often key components in the pathways signaling cell
cycle arrest and apoptosis.
We have found that primary Msh2- and Msh6-null MEFs, as
well as SV40-transformed Msh2-null MEFs, demonstrate
increased survival and viability post-UVB compared to appropri-
ate isogenic wild-type control cells (Young et al, 2003; Peters et al,
2003). Speci¢cally, these Msh2- and Msh6-null MEFs experience
lower levels of apoptosis 48 h after UVB exposure. Biologic con-
sequences of UVB radiation arise from both UV-induced photo-
products and oxidative DNA damage. Therefore, it is not clear
which component of the UVB-induced DNA damage was pro-
cessed di¡erently by these MMR-de¢cient MEFs. However, de
Wind et al have shown, that ES cells derived from Msh2-null
mice are tolerant to UVC radiation, which forms primarily UV
photoproducts, and exhibit reduced levels of UVC-induced
apoptosis compared to wild-type ES cells.3
The e¡ect of MMRde¢ciency on UV-induced cell cycle arrest
has not been examined. However, Msh2-null MEFs (Peters et al,
2003) and an MSH6-de¢cient human lymphoblastoid cell line
(Duckett et al, 1999) both exhibit reduced UV-induced p53 activa-
tion, compared to wild-type controls.
In summary, loss of MMR has a minimal e¡ect on UV-in-
duced cytotoxicity in transformed and tumor-derived cell lines.
However, in nontransformed primary cells loss of MMR is asso-
ciated with a decrease in apoptosis, suggesting that these proteins
are an important component in the initiation of apoptosis follow-
ing UV irradiation, thus protecting against UV-induced muta-
genesis and tumorigenesis.
MMR AND UV: PHYSIOLOGIC AND CLINICAL DATA
To date, there are few studies addressing MMR protein levels in
human skin cancer samples. Varying levels of microsatellite
instability are observed in melanoma and basal cell carcinoma
(Sardi et al, 2000; Hussein et al, 2001a; 2001b; Kroiss et al, 2001;
2002; Alvino et al, 2002); however, this indicates that MMR
function has probably been lost, but not that loss of MMR is
involved in the etiology of the disease. Loss of MMR, however,
has been found to be associated with a more aggressive basal cell
carcinoma (Staibano et al, 2001) and decreased survival in patients
with melanoma (Korabiowska et al, 2000).
It has been demonstrated that levels of MMR proteins are
increased in premalignant skin lesions over levels in normal skin,
and that levels sharply decrease with transition into squamous cell
carcinoma or melanoma (Hussein et al, 2001b; 2002; Liang et al,
2001). It has been proposed that the increased levels of MMR
proteins observed in premalignant human skin lesions re£ect
induction of MMR as a response to either continued sun expo-
sure and/or accumulated DNA damage during the development
of squamous cell carcinoma (Liang et al, 2001). Conversely, other
studies have found that MMR levels are increased in the skin
tumor over that of the adjacent normal tissue (Rass et al, 2000;
2001).
Studies performed using cell-free extracts and cell culture sug-
gest a role for MMR proteins in communicating the presence of
UV-induced DNA damage to the cell and e¡ecting protective
cellular response mechanisms (described in previous sections).
The strongest data supporting the concept that MMR could pro-
tect against UV-induced tumorigenesisby in£uencing protective
cellularresponses are studies demonstrating that Msh2-null mice
chronically exposed to UVB have an increased propensity for de-
veloping skin cancer4 (Meira et al, 2001;Yoshino et al, 2002).
CONCLUSION
MMR is necessary for the repair of postreplicative DNA errors.
Additionally, MMR has been shown to be involved in the
response of cells to a wide range of exogenous DNA damage.
Prior to most studies speci¢cally addressing the role of MMR
in post-UV responses, Siede and Eckardt-Schupp (1986) pos-
tulated that MMR may process UV-induced DNA adducts as
3V. Borgdor¡ and N. deWind, personal communication, 2002.
4L.C. Young et al, unpublished data.
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replicative mismatches. Subsequent research has since supported
the model put forth by Wang et al (1999), however, that error-
prone translesion synthesis inserts an incorrect nucleotide oppo-
site the photoproduct, thus producing a photoproductmismatch
compound lesion. Human MutSa binds to these lesions and di-
rects removal of the nucleotides by canonical MMR processing
(Wang et al, 1999).
More recent studies demonstrate a role for MMR proteins in
cellular responses to a variety of DNA adducts, and we have
shown that MMR-de¢cient cells are resistant to UVB-induced
apoptosis (Peters et al, 2003;Young et al, 2003), which would elim-
inate mutated cells. Additionally, although studies indicate that
MMRdoes not have a direct role in theTCRof CPD photopro-
ducts, MMR may indirectly facilitate removal of UV-induced
adducts through cell cycle arrest,5 thus suppressing mutagenesis.
We propose that the Hays model can be expanded to include
post-UVprotective cellular responses such as cell arrest and apop-
tosis (Fig 1) and that an MMR-de¢cient cell is unable to respond
fully to UV-induced DNA damage and is predisposed to
malignant transformation. In whole-organism models, this pre-
disposition is ampli¢ed by the mutator phenotype inherent to
MMR-de¢cient cells; genes encoding proteins important to da-
mage response contain microsatellites and are targets for muta-
tion in MMR-de¢cient cells. The body of literature reviewed
here is consistent with MMR being an important component in
the cellular responses to UV and hence in the prevention of UV-
induced skin cancer (Table II).
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